Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash Flows From Operating Activities:
Net loss	$ (407,292)	$ (376,063)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and Amortization	129,098	187,395
Stock compensation expense	261,833	543,972
Bad debt expense	33,576	7,033
(Increase) decrease in:
Trade receivables	(192,273)	215,742
Prepaids and other assets	(3,726)	(135,416)
(Decrease) increase in:
Accounts payable	178,505	167,123
Accrued liabilities	(51,968)	(34,778)
Deferred revenue	(99,057)	(86,577)
Net cash (used in) provided by operating activities	$ (151,304)	488,431
Cash Flows From Investing Activities:
Cash advanced on note receivable		(400,000)
Purchase of property and equipment	$ (18,586)	$ (8,997)
Purchase of marketable securities	(4,639,036)
Net cash used in investing activities	(4,657,622)	$ (408,997)
Cash Flows From Financing Activities:
Proceeds from employee stock plans	$ 98,976	98,414
Proceeds from issuance of note payable		8,213
Dividends paid	$ (2,644)	(154,473)
Payments on notes payable and capital leases	(55,894)	(106,198)
Net cash provided by (used in) financing activities	40,438	(154,044)
Net decrease in cash and cash equivalents	(4,768,488)	(74,610)
Cash and cash equivalents at beginning of period	11,325,572	3,352,559
Cash and cash equivalents at end of period	$ 6,557,084	$ 3,277,949
Supplemental Disclosure of Cash Flow Information:
Cash paid for income taxes
Cash paid for interest	$ 8,680	$ 10,016
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Common stock to pay accrued liabilities	987,885	745,248
Dividends accrued on preferred stock	$ 199,388	$ 154,473